Advertising
Showing 1 to 15 of 16 entries
TOP PICK
64.83 One of the top 30 stocks on the TSX for the past three years. They develop and maintain supply chain management software, so they are right in the sweet spot now. Main clients health care providers in the US and companies with complex distribution. They just reported record results and back log. This will be a $100 stock in the future. Yield 0.6%
consulting
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. EPS missed expectations though revenues beat expectations. Revenues increased by 12% you. The emphasis for companies on supply chain management will be a tailwind for them. They will continue to grow top line and if they benefit from FX then the company can perform quite well. Unlock Premium - Try 5i Free

consulting
HOLD
Inventory management. Leaders in the healthcare field. Excel in complex distribution. Growing fast. Sweet spot right now.
consulting
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenu growth has accelerated recently. While the company is expensive on a price to earnings basis, it is still cheaper than most tech stocks on a price to sales basis. Unlock Premium - Try 5i Free

consulting
BUY
Someone should buy them out. Delivered a good quarter last night.
consulting
TOP PICK
They develop and implement software in healthcare in the US as well as others clients for warehousing, distribution, and so on. They are growing their recurring revenues. They are changing from a perpetual license model to a SAS model, causing a temporary drop in revenues. Trading at two times revenues. (Analysts’ price target is $18.43)
consulting
PAST TOP PICK

(A Top Pick July 21/16. Up 8.81%.) They make the lives of hospitals more efficient with some of their supply chain management work. A high recurring revenue. Earnings are expected to double by April 2018, going from $.24-$.51, giving you a 22X PE. They are free cash flow positive. ROE is very good at 24%. Feels this still has further upside.

consulting
TOP PICK

This is in the hospital supply chain management. It has roughly $120 million market cap. They have 2 new modules, one for in-house pharmacies in hospitals, as well as operating rooms. It keeps track of where all the stuff is. That has doubled the revenue potential per hospital. Their pipeline sales over the last year has increased by more than the factor of 3. Year-over-year sales were up 26%. Year-over-year earnings, free cash flow and EBITDA grew over 32%. Dividend yield of 1.21%.

consulting
PAST TOP PICK

(A Top Pick March 16/16. Up 13.87%.) This is a great management team that has been around for a long time, and own quite a few of the shares. There was some weird selling pressure at the end of last year. He expects to see growth on a continuing basis.

consulting
TOP PICK

Supply chain management for hospitals. Garbage cans with RFID tags. They do supply chain throughout the hospital. This is one of the cheapest entry points. It is well owned by management.

consulting
PAST TOP PICK

(Top Pick Mar 19/15, Down 23.18%) A hospital cart helps with automatic reordering as well as ensuring all consumables are billed to the patient.

consulting
COMMENT

Their key is supply chain management within the 4 walls of a hospital, giving them better efficiencies and inventory control. Have an extremely large recurring revenue business. Expected to have earnings growth of 62% this year, giving a PE multiple of 32X, which is not cheap, but earnings next year is expected to be just as brisk giving a PE multiple of 19X. He thinks there is opportunity to continue to win more hospitals. Good opportunity for a one-year investment.

consulting
BUY on WEAKNESS

It is not early days. The stock is fairly expensive, but he would look at it on a pullback. It is way ahead of itself right now.

consulting
TOP PICK

Very illiquid stock. Don’t rush out with market orders. Keep orders under $10. 3.3% cash flow yield. 42% growth next year.

consulting
TOP PICK
Have about $11/12 million in cash and $23/24 million in sales. Profitable. Trading at half X sales. Cheap. Good management.
consulting
Showing 1 to 15 of 16 entries

Tecsys Inc(TCS-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Tecsys Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Tecsys Inc(TCS-T) Frequently Asked Questions

What is Tecsys Inc stock symbol?

Tecsys Inc is a Canadian stock, trading under the symbol TCS-T on the Toronto Stock Exchange (TCS-CT). It is usually referred to as TSX:TCS or TCS-T

Is Tecsys Inc a buy or a sell?

In the last year, 4 stock analysts published opinions about TCS-T. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Tecsys Inc.

Is Tecsys Inc a good investment or a top pick?

Tecsys Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Tecsys Inc.

Why is Tecsys Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Tecsys Inc worth watching?

4 stock analysts on Stockchase covered Tecsys Inc In the last year. It is a trending stock that is worth watching.

What is Tecsys Inc stock price?

On 2022-01-27, Tecsys Inc (TCS-T) stock closed at a price of $40.6.